Moleculight, Inc. is a Toronto-based company specializing in advanced imaging technologies for the medical field. The organization focuses on developing innovative solutions that enhance the detection and management of wounds, particularly in diabetic patients. By leveraging proprietary fluorescence imaging technology, Moleculight aims to improve clinical outcomes through more accurate assessments of wound conditions. Their commitment to research and development positions them at the forefront of medical device innovation, addressing critical healthcare challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#118 in Toronto

#1,164 in Canada

#45,039 in the World

Toronto, Canada

Moleculight, Inc.

Forward Citations = 122

28 inventors:

Nitesh Mistry (11 out of 12 patents)

Simon Treadwell (8 out of 38 patents)

Danielle Dunham (8 out of 9 patents)

4. Todd Daynes (6 out of 14 patents)

5. Todd Meaney (6 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Moleculight, Inc.. Retrieved from https://idiyas.com/company/moleculight

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]